| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1e5fbdb2b31c9d7af515b9aa72d68221
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_91fca07cdbc15d3f78a73cd9ad73c831
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4d20f8369571c97a20bf6f625fbfb3a5 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-0261 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2857 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00 |
| filingDate |
2017-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d568f2c4c0a14e7831ebc21f01d9a501
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_939e56cd46a084b5d90f302b367813a9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5c6fdc0719a1db454fda8405a3ac830
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e001d072f50a3c82468b6fb4079c96f2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab8069cf04d4c41f54f53a5c917d8c86 |
| publicationDate |
2017-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2017125502-A1 |
| titleOfInvention |
Substance that inhibits p2y12 receptor, for use in the preventive treatment of systemic sclerosis in patients with raynaud's phenomenon and a dysimmunity |
| abstract |
The present invention relates to a substance that inhibits P2Y12 receptor for use in the preventive treatment of systemic sclerosis in patients with Raynaud's phenomenon and a dysimmunity. |
| priorityDate |
2016-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |